Wednesday, August 3, 2022

< + > U.S. Prescription Drug Pricing Doesn’t Favor The Patient: Case Of Sub-Optimal Market For Cancer Pharmaceuticals

It’s no surprise people say the healthcare system’s pricing is “rigged.” The drug supply chain is riddled with sub-optimal market features, none of which favor the patient. The blame for high drug prices and out-of-pocket spending goes beyond drug makers, to include PBMs, insurers, and hospitals.

No comments:

Post a Comment

< + > Healthcare Interoperability, Health Tech Ecosystem, Trust, Policy, and Much More at The Sequoia Project and Carequality Annual Meeting

The past 2 days we’ve been diving into the world of healthcare interoperability, CMS’ health tech ecosystems and a wide variety of related t...